Nachrichten und Videos - GlobeNewsWire Europe - Seite 2

L'Organisation Mondiale de la Santé (OMS) reconnaît le GKT831 en tant que premier représentant de la classe thérapeutique des inhibiteurs des NOX Le nouveau segment commun « naxib » approuvé par l'OMS entérine les inhibiteurs de NOX en tant que nouvelle classe thérapeutique La classe thérapeutique des inhibiteurs des NOX possède un fort potentiel dans les maladies fibrotiques, inflammatoires, neurodégénératives et oncologiques ARCHAMPS, France, 22 juill. 2019 (GLOBE NEWSWIRE) --...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LIMITED (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of...

Fort Worth, Texas - July 18, 2019 Emerge Energy Services LP (OTC: EMESZ) together with its subsidiaries and certain affiliates (the "Company") today announced that the Company has voluntarily filed for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on July 15, 2019. The case is being jointly administered under Emerge Energy Services LP et al Case Number: 19-11563. The Company has received a commitment for debtor in possession ("DIP")...

Mechelen, België; 18 juli 2019, 22:01 CET; gereglementeerde informatie - Galapagos NV (Euronext & NASDAQ: GLPG) heeft een kennisgeving van belangrijke deelneming ontvangen van Van Herk Investments B.V. Overeenkomstig de Belgische transparantiewetgeving [1] heeft Galapagos op 16 juli 2019 een kennisgeving van belangrijke deelneming ontvangen van Van Herk Investments B.V., waarin staat dat zij 5.792.737 stemrechten in Galapagos bezit in de vorm van aandelen (4.899.498) en American Depository...

Mechelen, Belgium; 18 July 2019; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency legislation [1] , Galapagos received a transparency notification on 16 July 2019 from Van Herk Investments B.V., who notified that it holds 5,792,737 of Galapagos' voting rights, consisting of ordinary shares (4,899,498) and American Depository Receipts (893,239). This represents 10.57% of...

DEBUT D'ANNEE PROMETTEUR Befimmo a publié ses résultats pour le premier semestre de l'exercice 2019. Le Rapport complet peut être consulté via le lien ci-dessous. Le résumé se trouve en page 3. BEFIMMO - Rapport Financier Semestriel 2019 - 18.07.2019 17h40 This announcement is distributed by West Corporation on behalf of West Corporation clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained...

PROMISING START OF THE YEAR Befimmo published its results for the first half of 2019. You can consult the full Report via the link hereafter. The executive summary can be found on page 3. BEFIMMO - Half-Yearly Financial Report 2019 - 18.07.2019 5.40 PM This announcement is distributed by West Corporation on behalf of West Corporation clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein....

VEELBELOVENDE START VAN HET JAAR Befimmo heeft haar resultaten voor de eerste helft van het boekjaar 2019 gepubliceerd. Het volledige Verslag is beschikbaar via de link hieronder. De samenvatting bevindt zich op pagina 3. BEFIMMO - Halfjaarlijks Financieel Verslag 2019 - 18.07.2019 17u40 This announcement is distributed by West Corporation on behalf of West Corporation clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of...

JCDecaux remporte le contrat de mobilier urbain publicitaire de 6 villes du Grand Paris Seine Ouest pour 15 ans Paris, le 18 juillet 2019 - JCDecaux SA (Euronext Paris : DEC), numéro un mondial de la communication extérieure, annonce avoir remporté, dans le cadre d'un appel d'offres, le contrat de mobilier urbain publicitaire de 6 villes du Grand Paris Seine Ouest, un Etablissement Public Territorial regroupant 8 communes, dont 6 sont concernées par ce nouveau contrat (1 gain : Vanves et 5...

JCDecaux wins advertising street furniture contract for six cities in the Grand Paris Seine Ouest area for a 15-year period Paris, July 18 th , 2019 - JCDecaux SA (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announced that following a competitive tender, it has won the advertising street furniture contract for six cities in the Grand Paris Seine Ouest area, an Etablissement Public Territorial (a public local authority created within Greater Paris) comprising eight...

GREENWICH, Conn. - July 18, 2019 - XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics solutions, has partnered with Elves & More of Northeast Ohio to surprise more than 500 children with new bikes on July 21. To keep anticipation high, the exact neighborhood will remain a secret until delivery day. This is the fourteenth year that XPO has supported Elves & More of Northeast Ohio. Troy Cooper, president of XPO Logistics, said, "Riding a bicycle is a natural...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LIMITED (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of...

NOVARTIS FINANCE S.A. / Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Continuing operations[1] net sales up 8% (cc[2], +4% USD) driven by: Cosentyx at USD 858 million, +25% (cc) mainly driven by continued strong US growth (+31%) Entresto grew to USD 421 million,...

NE PAS DIFFUSER AUX ETATS-UNIS D'AMERIQUE, CANADA, JAPON ET AUSTRALIE CE COMMUNIQUE NE CONSTITUE PAS UNE OFFRE ET EST DIFFUSE POUR INFORMATION UNIQUEMENT ACTEOS (la « Société ») annonce le succès de l'augmentation de capital par émission d'actions ordinaires nouvelles avec maintien du droit préférentiel de souscription des actionnaires existants, lancée le 20 juin 2019. A l'issue de la période de souscription qui s'est achevée le 15 juillet 2019, 1.104.674 actions nouvelles ont été...

GREENWICH, Conn. - July 17, 2019 - XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics solutions, will send 33 US company drivers to the National Truck Driving Championships (NTDC) after their victories at the state level. The NTDC event, known as the "Super Bowl of Safety," will be held August 14-17, 2019 in Pittsburgh, Pennsylvania. Over the past decade, XPO has had more NTDC Grand Champions than any other US carrier. The company's state winners competing...

Cette étude élargit les indications cliniques potentielles pour ce composé phare Essai financé par une subvention des National Institutes of Health aux États-Unis ARCHAMPS, France, 17 juill. 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext Paris & Bruxelles : FR0013399474 - GKTX) société biopharmaceutique et leader des thérapies NOX, annonce aujourd'hui l'approbation de l 'IND « Investigational New Drug » de la FDA aux États-permettant l'initiation d'une étude de Phase 2 avec le GKT831,...

Study expands potential clinical indications for lead compound Trial fully funded via a grant from the United States National Institutes of Health ARCHAMPS, France, July 17, 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext Paris & Brussels: FR0013399474 - GKTX) a biopharmaceutical company and the leader in NOX therapies, announced today that the United States Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application allowing the initiation of a Phase 2 trial of...

Second Quarter Highlights Revenue of NOK 1 304 million in the quarter with growth of 49 percent from previous year EBITDA of NOK 114 million in the quarter First Geo and AGR merger completed, presented as a new segment AGR MHWirth completed acquisition of Bronco Manufacturing in June Order intake of NOK 1.8 billion in the quarter, resulting in order backlog of NOK 3.5 billion Media Contact Leif Borge Chief Financial Officer Tel: +47 917 86 291 E-mail: [email protected] Akastor is a...

LYON, France, 16 juill. 2019 (GLOBE NEWSWIRE) -- L'Assemblée Générale Mixte des actionnaires de la Société ERYTECH Pharma (Euronext : ERYP - Nasdaq : ERYP) s'est réunie à Paris le vendredi 21 juin 2019. L'Assemblée Générale a approuvé toutes les résolutions soutenues par le Conseil d'administration, en ce compris : Nomination de Jean-Paul KRESS en tant qu'administrateur. Il a été par la suite nommé au poste de Président du Conseil d'administration ; Renouvellement des mandats...

LYON, France and CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP) announced that its 2019 Annual General Meeting was held in Paris on Friday, June 21, 2019. At the meeting, all resolutions for which management recommended a vote in favor, were adopted, including: Appointment of Jean-Paul KRESS as director; he was subsequently appointed to the position of Chairman of the Board of Directors; Renewal of the term of office of each of the following as...